Clinical trial
Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon
NCT02018627
Study timeline
Study start (unknown)2014-04-01Date precision: month
Registry last updated2019-10-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 1 Diabetesunresolved
Interventions
Xeris glucagonDRUG
Lilly glucagonDRUG
Sponsors & collaborators
Steven J. Russell, MD, PhDlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02018627 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.